戻る Agenda
Session 4: Egypt Townhall
Session Chair(s)
Dalia Abou Hussein
QA General Manager
Egyptian Drug Authority (EDA), Egypt
In this session hosted by the Egyptian Drug Authority (EDA), Egyptian authorities will present the vision for 2030, opportunities and latest developments in the country.
Speaker(s)
EDA’s Establishment and Efforts towards Alignment with International Standards
Aiman S. El-Khatib
Egyptian Drug Authority (EDA), Egypt
Vice President
EDA Efforts on Investment and Localization within the regulatory framework
Yasin Ragaey
Egyptian Drug Authority (EDA), Egypt
Chairman Assistant for Media affairs & Investment Support in the Pharma Sector
EDA’s path towards International Standards
Asmaa Fouad
Egyptian Drug Authority , Egypt
General Manager, Biological and Innovative Products and Clinical Studies
Medhat Al-Ghobashy
Egyptian Drug Authority (EDA), Egypt
Former EDA Advisor for Regulatory & Reference Labs
EDA’s collaborative initiatives
Riad Armanious
EVA Pharma, Egypt
Vice chairman, Chamber of Pharmaceutical Industry & CEO,
EDA’s collaborative initiatives
Representative Invited
EFRP, Egypt